Empagliflozin -- Benefit Assessment According to §35a Social Code Book V [Internet].

The aim of this report was to assess the added benefit of empagliflozin for the treatment of adults with type 2 diabetes mellitus in the following approved subindications:

http://ift.tt/2seQHjH